Packages (Simulation)
Quality Guarantee
Certificate
Active Interleukin 31 (IL31)
- Product No.APB179Hu01
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Buffer Formulation20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
- Traits Freeze-dried powder
- Purity> 90%
- Isoelectric Pointn/a
- ApplicationsCell culture; Activity Assays.
- Downloadn/a
- UOM 10µg50µg 200µg 1mg 5mg
- FOB
US$ 308
US$ 770
US$ 1540
US$ 4620
US$ 11550
For more details, please contact local distributors!
ACTIVITY TEST
USAGE
Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
-
BCA Protein Quantification Kit
-
Molecular Mass Marker for Protein
-
Monoclonal Antibody Customized Service
-
Polyclonal Antibody Customized Service
-
Protein Activity Test Experiment Service
-
Electrophoretic Mobility Shift Assay (EMSA) Experiment Service
-
Buffer
-
Lentivirus Packaging Experiment Service
-
Adenovirus Packaging Experiment Service
-
Real Time PCR Experimental Service
-
Spike RBD Protein (S-RBD)
-
Protein G
-
Protein A
| Magazine | Citations |
| allergy and clinical immunology | Increased serum levels of Interleukin-31 could modulate inflammatory processes in multiple sclerosis Siaic-Review:Source |
| BMC Immunol | Increased levels of interleukin 31 (IL-31) in osteoporosis PubMed: 2644965 |
| Sci Rep. | Interleukin-31 expression and relation to disease severity in human asthma pmc:PMC4783779 |
| Exp Dermatol. | Immediate-type allergic and protease-mediated reactions are involved in scratching behaviour induced by topical application of Dermatophagoides farinae extract in NC/Nga mice. pubmed:28191683 |
| Nat Commun. | The transcription factor EPAS1 links DOCK8 deficiency to atopic skin inflammation via IL-31 induction. pubmed:28067314 |
| Experimental Dermatology | Immediate-type allergic and protease-media ted reactions are involved in scratching behavior induced by topical application of Dermatophagoides farinae extract in NC/Nga mice doi:10.1111 |
| アトピー性皮膚炎の痒みの発症機序に関する研究 | |
| Indian Journal of Public Health Research & Development | Determination the Role of Interleukin 31 (IL-31) Levels in Three Real Allergic Diseases (Asthma, Rhinitis, Urticaria) |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| APB179Hu01 | Active Interleukin 31 (IL31) | Cell culture; Activity Assays. |
| RPB179Hu01 | Recombinant Interleukin 31 (IL31) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB179Hu01 | Polyclonal Antibody to Interleukin 31 (IL31) | WB; IHC; ICC; IP. |
| MAB179Hu22 | Monoclonal Antibody to Interleukin 31 (IL31) | WB; IHC; ICC; IP. |
| SEB179Hu | ELISA Kit for Interleukin 31 (IL31) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCB179Hu | CLIA Kit for Interleukin 31 (IL31) | Chemiluminescent immunoassay for Antigen Detection. |
| LMB179Hu | Multiplex Assay Kit for Interleukin 31 (IL31) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |